Digestive Disease Week, the annual meeting sponsored by the American Association for the Study of Liver Diseases, American Gastroenterological Association, American Society for Gastrointestinal ...

Washington (May 14, 2024) — Cancer-related studies, including a diagnostic tool for gastric cancer and trends in gallbladder and colorectal cancers, will be presented this week at Digestive Disease ...

About SKYRIZI® (risankizumab-rzaa)SKYRIZI is an interleukin-23 (IL-23) inhibitor that selectively blocks IL-23 by binding to its p19 subunit.2 IL-23, a cytokine involved in inflammatory processes, is ...

Palisade Bio's PALI-2108 will be presented at Digestive Disease Week 2025, highlighting its potential in ulcerative colitis treatment. Palisade Bio's lead program PALI-2108 has been recognized, being ...

SAN DIEGO, CA. (MAY 6, 2025) — Cancer related studies were among nearly 6,000 abstracts presented at Digestive Disease Week® (DDW) 2025, including research on AI in patient communication, polyp ...

SAN DIEGO — The session started with a question that many in the audience at a May 4 session of Digestive Disease Week (DDW) 2025 seemed to relate to: “How many of you find yourself squeezing workouts ...

The MarketWatch News Department was not involved in the creation of this content. Poster presentation scheduled for Tuesday, May 5th at 12:30 PM CDT Denver, CO, April 16, 2026 (GLOBE NEWSWIRE) -- ...

- Recent safety and efficacy data in both Ulcerative Colitis and Pouchitis continue to support MH002’s potential in indications characterized by mucosal damage and inflammation. GHENT, ...

At the 2026 Digestive Disease Week (DDW) conference, there was significant buzz around certain pharma and medical device readouts, with key results spanning across oesophageal disorders, inflammatory ...

Single-Fiber Digital Pathology Quantification Reveals Multidimensional Fibrosis Architecture in Eosinophilic Esophagitis Beyond Collagen Area Ratio These results underscore the value of PharmaNest's ...

Ajay Goel, PhD, AGAF, explains the significance of 2 new studies that found that early-onset colorectal cancer (EOCRC) and recurrence in CRC could both be predicted using new blood and tissue tests.

ZYMFENTRA® (infliximab-dyyb) is a prescription medicine used as an injection under the skin (subcutaneous injection) by adults for the maintenance treatment of moderately-to-severely active ulcerative ...